<code id='7FF6088F9C'></code><style id='7FF6088F9C'></style>
    • <acronym id='7FF6088F9C'></acronym>
      <center id='7FF6088F9C'><center id='7FF6088F9C'><tfoot id='7FF6088F9C'></tfoot></center><abbr id='7FF6088F9C'><dir id='7FF6088F9C'><tfoot id='7FF6088F9C'></tfoot><noframes id='7FF6088F9C'>

    • <optgroup id='7FF6088F9C'><strike id='7FF6088F9C'><sup id='7FF6088F9C'></sup></strike><code id='7FF6088F9C'></code></optgroup>
        1. <b id='7FF6088F9C'><label id='7FF6088F9C'><select id='7FF6088F9C'><dt id='7FF6088F9C'><span id='7FF6088F9C'></span></dt></select></label></b><u id='7FF6088F9C'></u>
          <i id='7FF6088F9C'><strike id='7FF6088F9C'><tt id='7FF6088F9C'><pre id='7FF6088F9C'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:7

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Readout Newsletter: Ironwood, Pfizer, FogPharma updates
          Readout Newsletter: Ironwood, Pfizer, FogPharma updates

          DavidLRyan/TheBostonGlobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourb

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Senate panel clears PBM, hopsital reforms

          Sens.RonWydenandMikeCrapopassedanewslateofpharmacybenefitmanagerreformsthroughtheFinanceCommittee.Ke